🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lobular Breast Carcinoma

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites📍 Newport Beach📍 Stanford📍 Miami Eli Lilly and Company · Tests: LY4337713 Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer NCT07214532NA49 sites📍 Phoenix📍 Scottsdale📍 Tucson Natera, Inc. · Tests: ctDNA-Guided Treatment Strategy Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery NCT04169542n/a4 sites📍 Conroe📍 Houston📍 League City M.D. Anderson Cancer Center · Tests: Questionnaire Administration Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors NCT07261631Phase 19 sites📍 Princeton📍 Montreal📍 Odense C Novartis Pharmaceuticals · Tests: 68Ga-NNS309, 177Lu-DFC413 Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer NCT03936478Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: MRIdian Radiation Treatment Unit Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer NCT02918474NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Decision Aid, Questionnaire Administration Perioperative Mindfulness Proposal NCT04049214NA1 site📍 Newport Beach Hoag Memorial Hospital Presbyterian · Tests: Meditation Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies NCT07309770Phase 21 site📍 Shanghai Sheng Zhang · Tests: SHR-A1811, Trastuzumab Rezetecan Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) NCT04985032n/a2 sites📍 Stuart📍 Tampa RPCR, Inc. · Tests: stereotactic body radiation therapy ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy NCT06185205Phase 21 site📍 Richmond Virginia Commonwealth University · Tests: Accelerated partial breast irradiation PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). NCT03713203NA1 site📍 Lille University Hospital, Lille · Tests: pagetex PDT Biomarkers to Detect Endocrine Therapy Resistance NCT06067503Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: 18F-fluorofuranylnorprogesterone, Liquid Biopsy, Positron Emission Tomography/Computed Tomography A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers NCT07117214Phase 11 site📍 Groningen Novartis Pharmaceuticals · Tests: [68Ga]Ga-DWJ155 Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors NCT07630961Phase 12 sites📍 Odense C📍 Chuo Ku Novartis Pharmaceuticals · Tests: 68Ga-DFC413, 68Ga-NNS309 Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer NCT04959474NA1 site📍 Philadelphia Thomas Jefferson University · Tests: Best Practice, Stereotactic Body Radiation Therapy, Resection, Sentinel Lymph Node Biopsy, Dietary Intervention Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial NCT06184750Phase 211 sites📍 Tucson📍 Chicago📍 Chicago National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Mammography, Questionnaire Administration, Tamoxifen Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ NCT06218303Phase 11 site📍 Pittsburgh Finn, Olivera, PhD · Tests: MUC1 Peptide Vaccine, Hiltonol®, Aromatase Inhibitor, Selective estrogen receptor modulator (SERM) Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery NCT07762885Phase 31 site📍 Shanghai Fudan University · Tests: Adjuvant Radiotherapy, tamoxifen A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease. NCT06561555Phase 21 site📍 Shanghai Fudan University · Tests: RC48 Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer NCT06984250n/a2 sites📍 Taipei📍 Taipei National Taiwan University Hospital · Tests: Hypofractionated Radiation Therapy A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer NCT07483307Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Neoadjuvant endocrine therapy Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) NCT06902311Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Breast Radiotherapy A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue NCT05837767NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Palliative radiotherapy Identifying and Caring for Individuals With Inherited Cancer Syndrome NCT04494945NA2 sites📍 Portland📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Genetic Counseling, Genetic Testing, Survey Administration Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women NCT03201861Phase 31 site📍 Shanghai RenJi Hospital · Tests: Paclitaxel, Cisplatin, EC to docetaxel or paclitaxel Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy NCT07711847NA1 site📍 New York HeroSupport SA · Tests: VENUS SHELL™ immobilization device InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples [68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) NCT07020806Phase 11 site📍 Sacramento University of California, Davis · Tests: [68Ga]Ga DOTA-5G Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer NCT06888388n/a16 sites📍 New Haven📍 Boston📍 New York Sir Mortimer B. Davis - Jewish General Hospital · Tests: Nipple Sparing Mastectomy (NSM), Skin-Sparing Mastectomy (SSM), Total (Simple) Mastectomy The PREDICT Registry: NCT03448926n/a30 sites📍 Scottsdale📍 La Jolla📍 San Mateo PreludeDx · Tests: Treatment recommendation surveys, 7-gene biosignature
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy